Carregant...
A stochastically curtailed single-arm phase II trial design for binary outcomes
Phase II clinical trials are a critical aspect of the drug development process. With drug development costs ever increasing, novel designs that can improve the efficiency of phase II trials are extremely valuable. Phase II clinical trials for cancer treatments often measure a binary outcome. The fin...
Guardat en:
| Publicat a: | J Biopharm Stat |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2022
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7614398/ https://ncbi.nlm.nih.gov/pubmed/35077268 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10543406.2021.2009498 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|